9 Aug 2017 14:30
PDMR DEALING NOTIFICATION
1 | Details of the person discharging managerial responsibilities/person closely associated | |||||
a) | Name | John Samuel | ||||
2 | Reason for the notification | |||||
a) | Position/status | Director | ||||
b) | Initial notification/Amendment | Initial notification | ||||
3 | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |||||
a) | Name | Tissue Regenix Group plc | ||||
b) | LEI | 213800PNOD5UHQUFJI36 | ||||
4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |||||
a) | Description of the financial instrument, type of instrument Identification code |
GB00B5SGVL29 | ||||
b) | Nature of the transaction | Subscription for ordinary shares | ||||
c) | Price(s) and volume(s) |
| ||||
d) | Aggregated information
| N/A
| ||||
e) | Date of the transaction | 9 August 2017 | ||||
f) | Place of the transaction | Outside a trading venue | ||||
PDMR DEALING NOTIFICATION
1 | Details of the person discharging managerial responsibilities/person closely associated | |||||
a) | Name | Alan Miller | ||||
2 | Reason for the notification | |||||
a) | Position/status | Director | ||||
b) | Initial notification/Amendment | Initial notification | ||||
3 | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |||||
a) | Name | Tissue Regenix Group plc | ||||
b) | LEI | 213800PNOD5UHQUFJI36 | ||||
4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |||||
a) | Description of the financial instrument, type of instrument Identification code |
GB00B5SGVL29 | ||||
b) | Nature of the transaction | Subscription for ordinary shares | ||||
c) | Price(s) and volume(s) |
| ||||
d) | Aggregated information
| N/A
| ||||
e) | Date of the transaction | 9 August 2017 | ||||
f) | Place of the transaction | Outside a trading venue | ||||
PDMR DEALING NOTIFICATION
1 | Details of the person discharging managerial responsibilities/person closely associated | |||||
a) | Name | Antony Odell | ||||
2 | Reason for the notification | |||||
a) | Position/status | Director | ||||
b) | Initial notification/Amendment | Initial notification | ||||
3 | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |||||
a) | Name | Tissue Regenix Group plc | ||||
b) | LEI | 213800PNOD5UHQUFJI36 | ||||
4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |||||
a) | Description of the financial instrument, type of instrument Identification code |
GB00B5SGVL29 | ||||
b) | Nature of the transaction | Subscription for ordinary shares | ||||
c) | Price(s) and volume(s) |
| ||||
d) | Aggregated information
| N/A
| ||||
e) | Date of the transaction | 9 August 2017 | ||||
f) | Place of the transaction | Outside a trading venue | ||||
PDMR DEALING NOTIFICATION
1 | Details of the person discharging managerial responsibilities/person closely associated | |||||
a) | Name | Jonathan Glenn | ||||
2 | Reason for the notification | |||||
a) | Position/status | Director | ||||
b) | Initial notification/Amendment | Initial notification | ||||
3 | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |||||
a) | Name | Tissue Regenix Group plc | ||||
b) | LEI | 213800PNOD5UHQUFJI36 | ||||
4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |||||
a) | Description of the financial instrument, type of instrument Identification code |
GB00B5SGVL29 | ||||
b) | Nature of the transaction | Subscription for ordinary shares | ||||
c) | Price(s) and volume(s) |
| ||||
d) | Aggregated information
| N/A
| ||||
e) | Date of the transaction | 9 August 2017 | ||||
f) | Place of the transaction | Outside a trading venue | ||||
PDMR DEALING NOTIFICATION
1 | Details of the person discharging managerial responsibilities/person closely associated | |||||
a) | Name | Paul Devlin | ||||
2 | Reason for the notification | |||||
a) | Position/status | Director | ||||
b) | Initial notification/Amendment | Initial notification | ||||
3 | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |||||
a) | Name | Tissue Regenix Group plc | ||||
b) | LEI | 213800PNOD5UHQUFJI36 | ||||
4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |||||
a) | Description of the financial instrument, type of instrument Identification code |
GB00B5SGVL29 | ||||
b) | Nature of the transaction | Subscription for ordinary shares | ||||
c) | Price(s) and volume(s) |
| ||||
d) | Aggregated information
| N/A
| ||||
e) | Date of the transaction | 9 August 2017 | ||||
f) | Place of the transaction | Outside a trading venue | ||||
PDMR DEALING NOTIFICATION
1 | Details of the person discharging managerial responsibilities/person closely associated | |||||
a) | Name | Steven Couldwell | ||||
2 | Reason for the notification | |||||
a) | Position/status | Director | ||||
b) | Initial notification/Amendment | Initial notification | ||||
3 | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |||||
a) | Name | Tissue Regenix Group plc | ||||
b) | LEI | 213800PNOD5UHQUFJI36 | ||||
4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |||||
a) | Description of the financial instrument, type of instrument Identification code |
GB00B5SGVL29 | ||||
b) | Nature of the transaction | Subscription for ordinary shares | ||||
c) | Price(s) and volume(s) |
| ||||
d) | Aggregated information
| N/A
| ||||
e) | Date of the transaction | 9 August 2017 | ||||
f) | Place of the transaction | Outside a trading venue | ||||
PDMR DEALING NOTIFICATION
1 | Details of the person discharging managerial responsibilities/person closely associated | |||||
a) | Name | Shervanthi Homer Vanniasinkam | ||||
2 | Reason for the notification | |||||
a) | Position/status | Director | ||||
b) | Initial notification/Amendment | Initial notification | ||||
3 | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |||||
a) | Name | Tissue Regenix Group plc | ||||
b) | LEI | 213800PNOD5UHQUFJI36 | ||||
4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |||||
a) | Description of the financial instrument, type of instrument Identification code |
GB00B5SGVL29 | ||||
b) | Nature of the transaction | Subscription for ordinary shares | ||||
c) | Price(s) and volume(s) |
| ||||
d) | Aggregated information
| N/A
| ||||
e) | Date of the transaction | 9 August 2017 | ||||
f) | Place of the transaction | Outside a trading venue | ||||
Tissue Regenix Group (TRX)